Coelho Rogerio Vivaldi Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Coelho Rogerio Vivaldi.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Coelho Rogerio Vivaldi. Coelho Rogerio Vivaldi is a Chief Commercial Officer in Spark Therapeutics, Inc. ($ONCE) and a EVP, Chief Global Therapeutics in Bioverativ Inc. ($BIVV) and a President and CEO in Sigilon Therapeutics, Inc. ($SGTX).
Address: C/O MINERVA NEUROSCIENCES, INC. 245 FIRST STREET SUITE 1800 CAMBRIDGE 02142 MA
Companies in which Coelho Rogerio Vivaldi is an Insider
Bioverativ Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Coelho Rogerio Vivaldi: EVP, Chief Global Therapeutics
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 08 2018
$BIVV Market Capitalization: $4637.62B
$BIVV Previous Close: $44.44
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sigilon Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Coelho Rogerio Vivaldi: President and CEO
Holdings: 22,222 shares
Latest Transaction: Dec 10 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Spark Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Coelho Rogerio Vivaldi: Chief Commercial Officer
Holdings: 19,716 shares
Current Value: $1,243,291
Latest Transaction: Jul 19 2016
$ONCE Market Capitalization: $2.00B
$ONCE Previous Close: $63.06
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Coelho Rogerio Vivaldi
Sentiment: All, BIVV, SGTX, ONCE
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 10 2020 | SGTX | Sigilon Therapeuti ... | Vivaldi Coelho Rogerio | President and CEO | Option Exercise | C | 0.00 | 22,222 | 0 | 0 | |
| Dec 10 2020 | SGTX | Sigilon Therapeuti ... | Vivaldi Coelho Rogerio | President and CEO | Buy | C | 0.00 | 22,222 | 0 | 22,222 | 0 to 22.2 K |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Vivaldi Coelho Rogerio | EVP, Chief Global T ... | Option Exercise | D | 44.51 | 56,615 | 2,519,934 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Vivaldi Coelho Rogerio | EVP, Chief Global T ... | Option Exercise | D | 44.51 | 113,230 | 5,039,867 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Vivaldi Coelho Rogerio | EVP, Chief Global T ... | Option Exercise | D | 0.00 | 42,727 | 0 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Vivaldi Coelho Rogerio | EVP, Chief Global T ... | Option Exercise | D | 0.00 | 14,230 | 0 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Vivaldi Coelho Rogerio | EVP, Chief Global T ... | Sell | D | 0.00 | 5,758 | 0 | 0 | 5.8 K to 0 (-100.00 %) |